pharmacogenomics

Neurologists treating patients who present with a small stroke or transient ischemic attack are now able to get PGx results to inform their prescription of Plavix within 24 hours.

Investigators from Atrium Health recently published a study comparing pretreatment and posttreatment testing, showing a strong benefit in a real-world clinical cohort.

The report is intended to ensure that the appropriate variants are included in clinical pharmacogenomic DPYD assays.